MAPT and Alzheimer disease: The hyperphosphorylated tau that is present abnormally in the AD brain is differentiated from transiently hyperphosphorylated tau by its capacity to capture normal tau, MAP1, and MAP2, thereby interfering with microtubule assembly (Durairajan et al., 2022).